OSI Pharmaceuticals rejected a .5-billion takeover bid from Astellas Pharma Inc., telling shareholders Monday the offer was too low. Astellas has attempted to acquire OSI for more than More
Apply online for Commercial Real Estate loans at RealEstateZoo.Com
